INTRODUCTION: The current algorithm for managing patients with indeterminate (Thy3) thyroid cytology is a thyroid lobectomy followed by a completion thyroidectomy depending on histology. We investigated whether sonographic and or cytological features in addition to clinical characteristics would predict the potential for malignancy in a cohort of patients with thyroid nodules of indeterminate cytology. METHODS: Perusing a clinical database of all patients undergoing ultrasonography guided fine needle aspiration (FNA) of thyroid nodules, we identified all Thy3 lesions. The demographic, ultrasonography and cytological details of benign and malignant groups were compared by t-test, chi-square test and, when appropriate, Fisher's exact test. Association between studied characteristics and malignancy was tested by binary logistic regression using single input. A p-value of <0.05 was considered significant. RESULTS: During the retrospective study period of January 2003 to July 2010, a total of 1,019 patients underwent FNA, of which 69 (6.8%) were classed as Thy3. Of these, 59 underwent surgical treatment and the histological outcomes were grouped as benign (n=42, 71.2%) and malignant (n=17, 28.8%). These groups were analysed for the predictive variables. Age, sex and sonological characters were similar in the two groups (p>0.05). The two microcalcifications observed were both in the malignant group. Among all the variables assessed, only the absence of normal follicular cells was associated with malignant nodules (univariate analysis, p=0.034). CONCLUSIONS: Malignancy was more common in Thy3 patients with an absence of normal follicular cells and such patients may therefore warrant a total thyroidectomy.
INTRODUCTION: The current algorithm for managing patients with indeterminate (Thy3) thyroid cytology is a thyroid lobectomy followed by a completion thyroidectomy depending on histology. We investigated whether sonographic and or cytological features in addition to clinical characteristics would predict the potential for malignancy in a cohort of patients with thyroid nodules of indeterminate cytology. METHODS: Perusing a clinical database of all patients undergoing ultrasonography guided fine needle aspiration (FNA) of thyroid nodules, we identified all Thy3 lesions. The demographic, ultrasonography and cytological details of benign and malignant groups were compared by t-test, chi-square test and, when appropriate, Fisher's exact test. Association between studied characteristics and malignancy was tested by binary logistic regression using single input. A p-value of <0.05 was considered significant. RESULTS: During the retrospective study period of January 2003 to July 2010, a total of 1,019 patients underwent FNA, of which 69 (6.8%) were classed as Thy3. Of these, 59 underwent surgical treatment and the histological outcomes were grouped as benign (n=42, 71.2%) and malignant (n=17, 28.8%). These groups were analysed for the predictive variables. Age, sex and sonological characters were similar in the two groups (p>0.05). The two microcalcifications observed were both in the malignant group. Among all the variables assessed, only the absence of normal follicular cells was associated with malignant nodules (univariate analysis, p=0.034). CONCLUSIONS:Malignancy was more common in Thy3 patients with an absence of normal follicular cells and such patients may therefore warrant a total thyroidectomy.
Authors: Marille E Herrmann; Virginia A LiVolsi; Theresa L Pasha; Shelley A Roberts; Eva M Wojcik; Zubair W Baloch Journal: Arch Pathol Lab Med Date: 2002-06 Impact factor: 5.534
Authors: Nia D Banks; Jeanne Kowalski; Hua-Ling Tsai; Helina Somervell; Ralph Tufano; Alan P B Dackiw; Michael R Marohn; Douglas P Clark; Christopher B Umbricht; Martha A Zeiger Journal: Thyroid Date: 2008-09 Impact factor: 6.568
Authors: Guido M Sclabas; Gregg A Staerkel; Suzanne E Shapiro; Bruno D Fornage; Steven I Sherman; Rena Vassillopoulou-Sellin; Jeffrey E Lee; Douglas B Evans Journal: Am J Surg Date: 2003-12 Impact factor: 2.565
Authors: A Belfiore; G L La Rosa; G A La Porta; D Giuffrida; G Milazzo; L Lupo; C Regalbuto; R Vigneri Journal: Am J Med Date: 1992-10 Impact factor: 4.965
Authors: M-L Matthey-Gie; S M Walsh; A C O'Neill; A Lowery; D Evoy; D Gibbons; R S Prichard; S Skehan; E W McDermott Journal: Ir J Med Sci Date: 2014-01-09 Impact factor: 1.568
Authors: David F Schneider; Linda M Cherney Stafford; Nicole Brys; Caprice C Greenberg; Courtney J Balentine; Dawn M Elfenbein; Susan C Pitt Journal: Endocr Pract Date: 2017-01-17 Impact factor: 3.443
Authors: Pietro Giorgio Calò; Fabio Medas; Rosa Santa Cruz; Francesco Podda; Enrico Erdas; Giuseppe Pisano; Angelo Nicolosi Journal: BMC Surg Date: 2014-03-06 Impact factor: 2.102